Twinbeech Capital LP Catalyst Pharmaceuticals, Inc. Transaction History

Twinbeech Capital LP

  • $4.99 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$11.69 - $15.02 $2.22 Million - $2.85 Million
189,810 Added 802.58%
213,460 $2.5 Million
Q2 2023

Aug 14, 2023
SELL
$11.5 - $18.08 $1.13 Million - $1.78 Million
-98,599 Reduced 80.65%
23,650 $317,000
Q1 2023

May 15, 2023
BUY
$14.34 - $21.05 $1.75 Million - $2.57 Million
122,249 New
122,249 $2.03 Million

Others Institutions Holding CPRX

# of Institutions
331
Shares Held
95.3M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.32B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email